11 analysts have expressed a wide range of opinions on Benefit Medical Programs MMSI over the previous quarter, providing a various set of opinions from bullish to bearish.
The desk under offers a snapshot of their latest scores, showcasing how sentiments have advanced over the previous 30 days and evaluating them to the previous months.
| Bullish | Considerably Bullish | Detached | Considerably Bearish | Bearish | |
|---|---|---|---|---|---|
| Whole Rankings | 4 | 4 | 3 | 0 | 0 |
| Final 30D | 0 | 1 | 0 | 0 | 0 |
| 1M In the past | 0 | 1 | 0 | 0 | 0 |
| 2M In the past | 3 | 1 | 2 | 0 | 0 |
| 3M In the past | 1 | 1 | 1 | 0 | 0 |
Insights from analysts’ 12-month worth targets are revealed, presenting a mean goal of $104.45, a excessive estimate of $114.00, and a low estimate of $92.00. Marking a rise of seven.18%, the present common surpasses the earlier common worth goal of $97.45.
Investigating Analyst Rankings: An Elaborate Research
The evaluation of latest analyst actions sheds gentle on the notion of Benefit Medical Programs by monetary specialists. The next abstract presents key analysts, their latest evaluations, and changes to scores and worth targets.
| Analyst | Analyst Agency | Motion Taken | Ranking | Present Worth Goal | Prior Worth Goal |
|---|---|---|---|---|---|
| Michael Petusky | Barrington Analysis | Maintains | Outperform | $114.00 | $114.00 |
| Michael Petusky | Barrington Analysis | Raises | Outperform | $114.00 | $100.00 |
| Mike Matson | Needham | Raises | Purchase | $109.00 | $105.00 |
| Larry Biegelsen | Wells Fargo | Raises | Equal-Weight | $103.00 | $85.00 |
| Craig Bijou | B of A Securities | Raises | Impartial | $103.00 | $92.00 |
| Mike Matson | Needham | Maintains | Purchase | $105.00 | $105.00 |
| Jason Bednar | Piper Sandler | Raises | Obese | $110.00 | $100.00 |
| Mike Matson | Needham | Raises | Purchase | $105.00 | $94.00 |
| Craig Bijou | B of A Securities | Raises | Impartial | $92.00 | $87.00 |
| Jason Bednar | Piper Sandler | Raises | Obese | $100.00 | $97.00 |
| Mike Matson | Needham | Raises | Purchase | $94.00 | $93.00 |
Key Insights:
- Motion Taken: Analysts steadily replace their suggestions primarily based on evolving market situations and firm efficiency. Whether or not they ‘Preserve’, ‘Increase’ or ‘Decrease’ their stance, it displays their response to latest developments associated to Benefit Medical Programs. This info offers a snapshot of how analysts understand the present state of the corporate.
- Ranking: Analysts unravel qualitative evaluations for shares, starting from ‘Outperform’ to ‘Underperform’. These scores provide insights into expectations for the relative efficiency of Benefit Medical Programs in comparison with the broader market.
- Worth Targets: Analysts present insights into worth targets, providing estimates for the long run worth of Benefit Medical Programs’s inventory. This comparability reveals tendencies in analysts’ expectations over time.
Navigating by way of these analyst evaluations alongside different monetary indicators can contribute to a holistic understanding of Benefit Medical Programs’s market standing. Keep knowledgeable and make data-driven selections with our Rankings Desk.
Keep updated on Benefit Medical Programs analyst scores.
Unveiling the Story Behind Benefit Medical Programs
Benefit Medical Programs Inc is a medical gear firm that develops and manufactures merchandise to be used in interventional cardiology, radiology, and endoscopy procedures. The agency stories two segments that are Cardiovascular and Endoscopy. The vast majority of the income is earned from the Cardiovascular phase. The USA generates the vast majority of the income.
Benefit Medical Programs’s Monetary Efficiency
Market Capitalization Evaluation: The corporate’s market capitalization is above the business common, indicating that it’s comparatively bigger in measurement in comparison with friends. This will counsel the next degree of investor confidence and market recognition.
Income Progress: Benefit Medical Programs displayed constructive ends in 3 months. As of 30 June, 2024, the corporate achieved a stable income development fee of roughly 5.61%. This means a notable improve within the firm’s top-line earnings. As in comparison with rivals, the corporate encountered difficulties, with a development fee decrease than the common amongst friends within the Well being Care sector.
Web Margin: Benefit Medical Programs’s internet margin is spectacular, surpassing business averages. With a internet margin of 10.57%, the corporate demonstrates robust profitability and efficient value administration.
Return on Fairness (ROE): Benefit Medical Programs’s monetary energy is mirrored in its distinctive ROE, which exceeds business averages. With a exceptional ROE of 2.83%, the corporate showcases environment friendly use of fairness capital and robust monetary well being.
Return on Belongings (ROA): Benefit Medical Programs’s ROA excels past business benchmarks, reaching 1.52%. This signifies environment friendly administration of belongings and robust monetary well being.
Debt Administration: The corporate maintains a balanced debt strategy with a debt-to-equity ratio under business norms, standing at 0.68.
Analyst Rankings: What Are They?
Analyst scores function important indicators of inventory efficiency, offered by specialists in banking and monetary techniques. These specialists diligently analyze firm monetary statements, take part in convention calls, and have interaction with insiders to generate quarterly scores for particular person shares.
Some analysts publish their predictions for metrics similar to development estimates, earnings, and income to supply further steerage with their scores. When utilizing analyst scores, it is very important remember that inventory and sector analysts are additionally human and are solely providing their opinions to buyers.
If you wish to preserve observe of which analysts are outperforming others, you may view up to date analyst scores alongside withanalyst success scores in Benzinga Professional.
Breaking: Wall Road’s Subsequent Massive Mover
Benzinga’s #1 analyst simply recognized a inventory poised for explosive development. This under-the-radar firm may surge 200%+ as main market shifts unfold. Click on right here for pressing particulars.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Information delivered to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.